Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pizzolo, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 99 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gerli, R; Lunardi, C; Vinante, F; Bistoni, O; Pizzolo, G; Pitzalis, C
      Role of CD30(+) T cells in rheumatoid arthritis: a counterregulatory paradigm for Th1-driven diseases

      TRENDS IN IMMUNOLOGY
    2. Vassilakopoulos, TP; Nadali, G; Angelopoulou, MK; Siakantaris, MP; Dimopoulou, MN; Kontopidou, FN; Rassidakis, GZ; Doussis-Anagnostopoulou, IA; Hatzioannou, M; Vaiopoulos, G; Kittas, C; Sarris, AH; Pizzolo, G; Pangalis, GA
      Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma

      HAEMATOLOGICA
    3. Krampera, M; Perbellini, O; Maggioni, A; Scognamiglio, F; Todeschini, G; Pizzolo, G
      Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia

      HAEMATOLOGICA
    4. Corato, A; Ambrosetti, A; Rossi, B; Vincenzi, C; Lambiase, A; Perona, G; Pizzolo, G; de Wynter, E; Nadali, G
      Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    5. Krampera, M; Tavecchia, L; Benedetti, F; Nadali, G; Pizzolo, G
      Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes

      HAEMATOLOGICA
    6. Bazzoni, F; Gatto, L; Lenzi, L; Vinante, F; Pizzolo, G; Zanolin, E; De Gironcoli, M
      Identification of novel polymorphisms in the human TNFR1 gene: distribution in acute leukemia patients and healthy individuals

      IMMUNOGENETICS
    7. Revoltella, RP; Robbio, LL; Liberati, AM; Reato, G; Foa, R; Funaro, A; Vinante, F; Pizzolo, G
      Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus invitro

      CELLULAR IMMUNOLOGY
    8. Trentin, L; Perin, A; Siviero, M; Piazza, F; Facco, M; Gurrieri, C; Galvan, S; Adami, F; Agostini, C; Pizzolo, G; Zambello, R; Semenzato, G
      B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-Cell proliferation

      CANCER
    9. Chilosi, M; Chiarle, R; Lestani, M; Menestrina, F; Montagna, L; Ambrosetti, A; Prolla, G; Pizzolo, G; Doglioni, C; Piva, R; Pagano, M; Inghirami, G
      Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    10. Chiarle, R; Budel, LM; Skolnik, J; Frizzera, G; Chilosi, M; Corato, A; Pizzolo, G; Magidson, J; Montagnoli, A; Pagano, M; Maes, B; De Wolf-Peeters, C; Inghirami, G
      Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma

      BLOOD
    11. Krampera, M; Fattovich, G; Scupoli, MT; Pizzolo, G
      Early decrease of Interferon-gamma(+) and interleukin-2(+) T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis C

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    12. Krampera, M; Antico, A; Vinante, F; Morosato, L; Pizzolo, G
      Lymphocyte membrane antigen expression and intracellular cytokine patternsin an asymptomatic patient with persistently high serum levels of IgE

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    13. Chilosi, M; Adami, F; Lestani, M; Montagna, L; Cimarosto, L; Semenzato, G; Pizzolo, G; Menestrina, F
      CD138/syndecan-1: A useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies

      MODERN PATHOLOGY
    14. Vinante, F; Krampera, M; Morosato, L; Rigo, A; Romagnani, S; Pizzolo, G
      Peripheral T lymphocyte cytokine profile (IFN gamma, IL-2, IL-4) and CD30 expression/release during measles infection

      HAEMATOLOGICA
    15. Todeschini, G; Murari, C; Bonesi, R; Pizzolo, G; Verlato, G; Tecchio, C; Meneghini, V; Franchini, M; Giuffrida, C; Perona, G; Bellavite, P
      Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    16. Krampera, M; Vinante, F; Tavecchia, L; Morosato, L; Chilosi, M; Romagnani, S; Zanolin, ME; Pizzolo, G
      Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    17. Vinante, F; Marchi, M; Rigo, A; Scapini, P; Pizzolo, G; Cassatella, MA
      Granulocyte-macrophage colony-stimulating factor induces expression of heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor and sensitivity to diphtheria toxin in human neutrophils

      BLOOD
    18. Vinante, F; Rigo, A; Papini, E; Cassatella, MA; Pizzolo, G
      Heparin-binding epidermal growth factor-like growth factor diphtheria toxin receptor expression by acute myeloid leukemia cells

      BLOOD
    19. Vinante, F; Rigo, A; Cassatella, MA; Pizzolo, G
      Interleukin-8 in acute myeloid leukemia

      BLOOD
    20. CHILOSI M; MORELLI L; LESTANI M; MENESTRINA F; AMBROSETTI A; PIZZOLO G; PAGANO M; WU D; CHIARLE R; INGHIRAMI G
      LACK OF P27(KIP1) IN HAIRY-CELL LEUKEMIA

      Modern pathology
    21. TODESCHINI G; TECCHIO C; MENEGHINI V; PIZZOLO G; VENERI D; ZANOTTI R; RICETTI MM; SOLERO P; APRILI F; PERONA G
      ESTIMATED 6-YEAR EVENT-FREE SURVIVAL OF 55-PERCENT IN 60 CONSECUTIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS TREATED WITH AN INTENSIVE PHASE-II PROTOCOL BASED ON HIGH INDUCTION DOSE OF DAUNORUBICIN

      Leukemia
    22. Nadali, G; de Wynter, EA; Perandin, F; Tavecchia, L; Vincenzi, C; Ambrosetti, A; Fornale, M; Perona, G; Pizzolo, G; Testa, NG
      Regulation of the proliferative potential of cord blood long-term culture-initiating cells (LTC-IC) by different stromal cell lines: implications forLTC-IC measurement

      HAEMATOLOGICA
    23. CORATO A; NADALI G; ROSSI B; AMBROSETTI A; LAMBIASE A; PIZZOLO G; PERONA G
      TRANSPLANTATION POTENTIAL OF HEMATOPOIETIC-CELLS COLLECTED FROM WHOLE-BLOOD OF PATIENTS TREATED WITH VACOP-B CHEMOTHERAPY PLUS FILGRASTIM (R-METHUG-CSF)

      Experimental hematology
    24. CHILOSI M; PIAZZOLA E; LESTANI M; BENEDETTI A; GUASPARRI I; GRANCHELLI G; ALDOVINI D; LEONARDI E; PIZZOLO G; DOGLIONI C; MENESTRINA F; MARIUZZI GM
      DIFFERENTIAL EXPRESSION OF P57(KIP2), A MATERNALLY IMPRINTED CDK INHIBITOR, IN NORMAL HUMAN PLACENTA AND GESTATIONAL TROPHOBLASTIC DISEASE

      Laboratory investigation
    25. VINANTE F; RIGO A; TECCHIO C; MOROSATO L; NADALI G; RICETTI MM; KRAMPERA M; ZANOLIN E; LOCATELLI F; GALLATI H; CHILOSI M; PIZZOLO G
      SERUM LEVELS OF P55 AND P75 SOLUBLE TNF RECEPTORS IN ADULT ACUTE-LEUKEMIA AT DIAGNOSIS - CORRELATION WITH CLINICAL AND BIOLOGICAL FEATURES AND OUTCOME

      British Journal of Haematology
    26. NADALI G; TAVECCHIA L; ZANOLIN E; BONFANTE V; VIVIANI S; CAMERINI E; MUSTO P; DIRENZO N; CAROTENUTO M; CHILOSI M; KRAMPERA M; PIZZOLO G
      SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME

      Blood
    27. CHILOSI M; DOGLIONI C; YAN ZQ; LESTANI M; MENESTRINA F; SORIO C; BENEDETTI A; VINANTE F; PIZZOLO G; INGHIRAMI G
      DIFFERENTIAL EXPRESSION OF CYCLIN-DEPENDENT KINASE-6 IN CORTICAL THYMOCYTES AND T-CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA/

      The American journal of pathology
    28. NADALI G; VINANTE F; CHILOSI M; PIZZOLO G
      SOLUBLE MOLECULES AS BIOLOGICAL MARKERS IN HODGKINS-DISEASE

      Leukemia & lymphoma
    29. DELIOS MM; ROMAGNANI P; SCALETTI C; ANNUNZIATO F; MANGHETTI M; MAVILIA C; PARRONCHI P; PUPILLI C; PIZZOLO G; MAGGI E; DELPRETE GF; ROMAGNANI S
      IN-VIVO CD30 EXPRESSION IN HUMAN-DISEASES WITH PREDOMINANT ACTIVATIONOF TH2-LIKE T-CELLS

      Journal of leukocyte biology
    30. CHILOSI M; DOGLIONI C; MENESTRINA F; LESTANI M; PIAZZOLA E; BENEDETTI A; PEDRON S; MONTAGNA L; PIZZOLO G; MARIUZZI GM; JANOSSY G
      EXPRESSION OF EXTRACELLULAR-MATRIX MOLECULES, PROLIFERATION MARKERS AND CYCLIN-DEPENDENT KINASE INHIBITORS IN INFLAMED TISSUES

      Biochemical Society transactions
    31. PIZZOLO G; VINANTE F; NADALI G; KRAMPERA M; MOROSATO L; CHILOSI M
      HIGH SERUM LEVEL OF SOLUBLE CD30 IN ACUTE PRIMARY HIV-1 INFECTION

      Clinical and experimental immunology
    32. FOA R; VITALE A; ANNINO L; CASTOLDI GL; CIMINO G; CUNEO A; LISO V; MANCINI MA; MECUCCI C; PANE F; PIZZOLO G; SAGLIO G; TAFURI A; TODESCHINI G; ZEPPARONI A
      A CENTRALIZED BIOLOGIC PROGRAM FOR ADULT ALL - A GIMEMA MULTICENTER STUDY

      Blood
    33. TODESCHINI G; MENEGHINI V; CANTINI M; SECCHI S; TECCHIO C; GRASSI A; VENERI D; AMBROSETTI A; SCOGNAMIGLIO F; PIZZOLO G; PERONA G
      RETREATMENT OF ADULT ALL PATIENTS RELAPSED EARLY AFTER AN INTENSIVE FIRST LINE THERAPY

      Blood
    34. TODESCHINI G; TECCHIO C; MENEGHINI V; PIZZOLO G; VENERI D; ZANOTTI R; RICETTI MM; SOLERO P; APRILI F; PERONA G
      THERAPEUTIC RESULTS IN 60 CONSECUTIVE ADULT PATIENTS AFFECTED BY ACUTE LYMPHOBLASTIC-LEUKEMIA (PROTOCOL ALLVR589)

      Blood
    35. CORATO A; PERANDIN F; TAVECCHIA L; VINCENZI C; ROSSI B; AMBROSETTI A; LAMBIASE A; PIZZOLO G; PERONA G; NADALI G
      STANDARD-DOSE CHEMOTHERAPY PLUS FILGRASTIM (R-METHUG-CSF) FOR AUTOLOGOUS MOBILIZATION IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Blood
    36. AMBROSETTI A; CORATO A; NADALI G; MENEGHINI V; CHILOSI M; ZANOTTI R; TODESCHINI G; GIOVANNINI M; PIZZOLO G
      RESPONSE TO PURINE ANALOGS IN HAIRY-CELL LEUKEMIA IS ASSESSABLE BY SOLUBLE CD25

      Blood
    37. NADALI G; TAVECCHIA L; ZANOLIN E; BONFANTE V; MUSTO P; CHILOSI M; MOROSATO L; PIZZOLO G
      HIGH SERUM LEVELS OF SOLUBLE CD30 RECOGNIZE AT DIAGNOSIS PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME

      Blood
    38. ZAMBELLO R; FACCO M; TRENTIN L; SANCETTA R; TASSINARI C; PERIN A; MILANI A; PIZZOLO G; RODEGHIERO F; AGOSTINI C; MEAZZA R; FERRINI S; SEMENZATO G
      INTERLEUKIN-15 TRIGGERS THE PROLIFERATION AND CYTOTOXICITY OF GRANULAR LYMPHOCYTES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASE OF GRANULARLYMPHOCYTES

      Blood
    39. MAVILIA C; SCALETTI C; ROMAGNANI P; CAROSSINO AM; PIGNONE A; EMMI L; PUPILLI C; PIZZOLO G; MAGGI E; ROMAGNANI S
      TYPE-2 HELPER T-CELL PREDOMINANCE AND HIGH CD30 EXPRESSION IN SYSTEMIC-SCLEROSIS

      The American journal of pathology
    40. VINANTE F; RIGO A; TECCHIO C; PATUZZO C; RICETTI MM; MOROSATO L; CASSATELLA MA; CHILOSI M; PIZZOLO G
      PREFERENTIAL RELEASE OF HIGH AMOUNTS OF INTERLEUKIN-8 BY MYELOID BLASTS SHOWING MONOCYTIC DIFFERENTIATION

      Haematologica
    41. NADALL G; TEVOCCHLA L; VINCENZI C; FOMALE M; DEWINTER EA; TESTA NG; PERONE G; PIZZOLO G
      DIFFERENTIAL REGULATION OF CORD-BLOOD DERIVED HEMATOPOIETIC-CELLS IN LONG-TERM CULTURE

      Experimental hematology
    42. CHILOSI M; BENEDETTI A; LESTANI M; PIZZOLO G; JANOSSY G
      EXPRESSION OF ECM MOLECULES, PROLIFERATION MARKERS, AND CDK-INHIBITORS IN INFLAMED TISSUES

      Immunology
    43. CHILOSI M; FACCHETTI F; NOTARANGELO LD; ROMAGNANI S; DELPRETE G; ALMERIGOGNA F; DECARLI M; PIZZOLO G
      CD30 CELL EXPRESSION AND ABNORMAL SOLUBLE CD30 SERUM ACCUMULATION IN OMENNS SYNDROME - EVIDENCE FOR A T-HELPER 2-MEDIATED CONDITION

      European Journal of Immunology
    44. FATTOVICH G; VINANTE F; GIUSTINA G; MOROSATO L; ALBERTI A; RUOL A; PIZZOLO G
      SERUM LEVELS OF SOLUBLE CD30 IN CHRONIC HEPATITIS-B VIRUS-INFECTION

      Clinical and experimental immunology
    45. GOTTARDI D; ALFARANO A; DELEO AM; STACCHINI A; ARAGNO M; RIGO A; VENERI D; ZANOTTI R; PIZZOLO G; CALIGARISCAPPIO F
      IN LEUKEMIC CD5(-CELLS THE EXPRESSION OF BCL-2 GENE FAMILY IS SHIFTEDTOWARD PROTECTION FROM APOPTOSIS() B)

      British Journal of Haematology
    46. TODESCHINI G; TECCHIO C; MENEGHINI V; PIZZOLO G; KRAMPERA M; AMBROSETTI A; VENERI D; NADALI G; FRANCHINI M; PERONA G
      ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN ELDERLY PATIENTS RECEIVING INTENSIVE TREATMENT - EXPERIENCE IN 26 CONSECUTIVE PATIENTS

      Blood
    47. TODESCHINI G; SCOGNAMIGLIO F; SHEIBAN I; TONNI S; PIZZOLO G; TECCHIO C; MENEGHINI V; PERONA G
      LACK OF MAJOR CARDIAC SIDE-EFFECTS FOLLOWING HIGH DOSE-INTENSITY OF DAUNORUBICIN (DNM) IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Blood
    48. CHILOSI M; DOGLIONI C; MAGALINI A; INGHIRAMI G; KRAMPERA M; NADALI G; RAHAL D; PEDRON S; BENEDETTI A; SCARDONI M; MACRI E; LESTANI M; MENESTRINA F; PIZZOLO G; SCARPA A
      P21 WAF1 CYCLIN-KINASE INHIBITOR EXPRESSION IN NON-HODGKINS-LYMPHOMAS- A POTENTIAL MARKER OF P53 TUMOR-SUPPRESSOR GENE-FUNCTION/

      Blood
    49. CHILOSI M; PIZZOLO G
      REVIEW OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE - BIOLOGICAL ASPECTS,METHODS OF DETECTION, AND SELECTED DIAGNOSTIC APPLICATIONS

      Applied immunohistochemistry
    50. CHILOSI M; PIZZOLO G
      BIOPATHOLOGIC FEATURES OF HODGKINS-DISEASE

      Leukemia & lymphoma
    51. PASINI F; BASSETTO MA; SABBIONI R; CETTO GL; SCOGNAMMIGLIO F; PIZZOLO G
      SOLUBLE CD30 (SCD30) SERUM LEVELS IN PATIENTS WITH EMBRIONAL CARCINOMA (EC) OR MIXED GERM-CELL TUMORS (GCT) WITH EMBRIONAL COMPONENT

      European journal of cancer
    52. VINANTE F; VASSANELLI A; ZANOTTI R; NADALI G; KRAMPERA M; VINCENZI C; MOROSATO L; CHILOSI M; PIZZOLO G
      CIRCULATING LEVELS OF SOLUBLE CD23 REFLECT CLINICAL AND BIOLOGICAL FEATURES OF LEUKEMIC B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS

      International journal of clinical & laboratory research
    53. NADALI G; VINANTE F; RIGO A; TECCHIO C; MOROSATO L; ZANOLIN E; PERONA G; CHILOSI M; PIZZOLO G
      CORRELATION BETWEEN CLINICAL-FEATURES AND CIRCULATING LEVELS OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN HODGKINS-DISEASE

      International journal of clinical & laboratory research
    54. DANIEL CK; DELPRETE G; DECARLI M; ZANCUOGHI G; VINANTE F; PIZZOLO G; DELIOS MM; ROMAGNANI S
      PREFERENTIAL EXPRESSION OF CD30 BY HUMAN CD4-CELLS PRODUCING TH2-TYPECYTOKINES( T)

      The FASEB journal
    55. DELPRETE G; DECARLI M; ALMERIGOGNA F; DANIEL CK; DELIOS MM; ZANCUOGHI G; VINANTE F; PIZZOLO G; ROMAGNANI S
      PREFERENTIAL EXPRESSION OF CD30 BY HUMAN CD4(-CELLS PRODUCING TH2-TYPE CYTOKINES() T)

      The FASEB journal
    56. ZAMBELLO R; LOUGHRAN TP; TRENTIN L; PONTISSO P; BATTISTELLA L; RAIMONDI R; FACCO M; SANCETTA R; AGOSTINI C; PIZZOLO G; SEMENZATO G
      SEROLOGIC AND MOLECULAR EVIDENCE FOR A POSSIBLE PATHOGENETIC ROLE OF VIRAL-INFECTION IN CD3-NEGATIVE NATURAL KILLER-TYPE LYMPHOPROLIFERATIVE DISEASE OF GRANULAR LYMPHOCYTES

      Leukemia
    57. TRENTIN L; PIZZOLO G; ZAMBELLO R; AGOSTINI C; MOROSATO L; SANCETTA R; ADAMI F; VINANTE F; CHILOSI M
      LEUKEMIC-CELLS IN HAIRY-CELL LEUKEMIA AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RELEASE SOLUBLE TNF RECEPTORS

      Leukemia
    58. PIZZOLO G; VINCENZI C; VINANTE F; NADALI G; JANOSSY G
      ORTHO PERMEAFIX(TM) FIXATION IS NOT SUITABLE FOR THE FLOW CYTOMETRIC DETECTION OF NUCLEAR TERMINAL TRANSFERASE IN ACUTE MYLOID LEUKEMIA-CELLS - REPLY

      Leukemia
    59. ROMAGNANI S; DELPRETE G; MAGGI E; CHILOSI M; CALIGARISCAPPIO F; PIZZOLO G
      CD30 AND TYPE-2 T-HELPER (TH2) RESPONSES (VOL 57, PG 726, 1995)

      Journal of leukocyte biology
    60. ROMAGNANI S; DELPRETE G; MAGGI E; CHILOSI M; CALIGARISCAPPIO F; PIZZOLO G
      CD30 AND TYPE-2 T-HELPER (TH2) RESPONSES

      Journal of leukocyte biology
    61. NADALI G; VINANTE F; STEIN H; TODESCHINI G; TECCHIO C; MOROSATO L; CHILOSI M; MENESTRINA F; KINNEY MC; GREER JP; LATZA U; PERONA G; PIZZOLO G
      SERUM LEVELS OF THE SOLUBLE FORM OF CD30 MOLECULE AS A TUMOR-MARKER IN CD30(-CELL LYMPHOMA() ANAPLASTIC LARGE)

      Journal of clinical oncology
    62. CALIGARISCAPPIO F; BERTERO MT; CONVERSO M; STACCHINI A; VINANTE F; ROMAGNANI S; PIZZOLO G
      CIRCULATING LEVELS OF SOLUBLE CD30, A MARKER OF CELLS PRODUCING TH2-TYPE CYTOKINES, ARE INCREASED IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND CORRELATE WITH DISEASE-ACTIVITY

      Clinical and experimental rheumatology
    63. PIZZOLO G; ROMAGNANI S
      CD30 MOLECULE (KI-1 AG) - MORE THAN JUST A MARKER OF CD30 LYMPHOMA

      Haematologica
    64. DELPRETE G; MAGGI E; PIZZOLO G; ROMAGNANI S
      CD30, TH2 CYTOKINES AND HIV-INFECTION - A COMPLEX AND FASCINATING LINK

      Immunology today
    65. MCDONALD PP; CASSATELLA MA; BALD A; MAGGI E; ROMAGNANI S; GRUSS HJ; PIZZOLO G
      CD30 LIGATION INDUCES NUCLEAR FACTOR-KAPPA-B ACTIVATION IN HUMAN T-CELL LINES

      European Journal of Immunology
    66. CHILOSI M; DOGLIONI C; MAGALINI A; SCARPA A; RAHAL D; LESTANI M; MENESTRINA F; PIZZOLO G
      P21 WAF1 CYCLIN-KINASE INHIBITOR EXPRESSION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMAS - A POTENTIAL MARKER OF P53 TUMOR-SUPPRESSOR GENE-FUNCTION/

      Blood
    67. TODESCHINI G; TECCHIO C; MENEGHINI V; PIZZOLO G; SCOGNAMIGLIO F; AMBROSETTI A; ZANOTTI R; VENERI D; DEGANI D; FRANCHINI M; PERONA G
      IMPROVED RESULTS IN 50 CONSECUTIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS WITH VERY HIGH DOSAGE OF DAUNORUBICIN IN INDUCTION (PROTOCOLALL VR589)

      Blood
    68. AMBROSETTI A; CORATO A; ZANOTTI R; NADALI G; TODESCHINI G; MENEGHINI V; RICETTI M; BENEDETTI F; PIZZOLO G
      HAIRY-CELL LEUKEMIA - SOLUBLE CD25 IN MONITORING THE RESPONSE TO TREATMENT WITH 2-CDA

      Blood
    69. FALINI B; PILERI S; PIZZOLO G; DURKOP H; FLENGHI L; STIRPE F; MARTELLI MF; STEIN H
      CD30 (KI-1) MOLECULE - A NEW CYTOKINE RECEPTOR OF THE TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY AS A TOOL FOR DIAGNOSIS AND IMMUNOTHERAPY

      Blood
    70. LATZA U; FOSS HD; DURKOP H; EITELBACH F; DIECKMANN KP; LOY V; UNGER M; PIZZOLO G; STEIN H
      CD30 ANTIGEN IN EMBRYONAL CARCINOMA AND EMBRYOGENESIS AND RELEASE OF THE SOLUBLE MOLECULE

      The American journal of pathology
    71. CHILOSI M; LESTANI M; PEDRON S; MONTAGNA L; BENEDETTI A; PIZZOLO G; MENESTRINA F
      A RAPID IMMUNOSTAINING METHOD FOR FROZEN-SECTIONS

      Biotechnic & histochemistry
    72. MENESTRINA F; LESTANI M; SCARPA A; VIALE G; BONETTI F; PIZZOLO G; CHILOSI M
      COMMON ACUTE LYMPHOBLASTIC LEUKEMIA-LYMPHOMA EXPRESSING CYTOKERATIN -A CASE-REPORT

      Virchows Archiv
    73. AMBROSETTI A; KRAMPERA M; VENERI D; MENEGHINI V; APRILI F; MARTINELLI G; PIZZOLO G; PERONA G
      EARLY LYMPHOID BLASTIC CRISIS FOLLOWING MAJOR KARYOTYPIC CONVERSION IN A CHRONIC MYELOID-LEUKEMIA PATIENT TREATED WITH INTERFERON-ALPHA

      International journal of clinical & laboratory research
    74. PIZZOLO G; RIGO A; VINANTE F; CHILOSI M
      PRESENCE OF INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN TRANSCRIPT IN AML BLASTS

      Leukemia
    75. PIZZOLO G; VINCENZI C; NADALI G; VENERI D; VINANTE F; CHILOSI M; BASSO G; CONNELLY MC; JANOSSY G
      DETECTION OF MEMBRANE AND INTRACELLULAR ANTIGENS BY FLOW-CYTOMETRY FOLLOWING ORTHO PERMEAFIX(TM) FIXATION

      Leukemia
    76. TODESCHINI G; MENEGHINI V; PIZZOLO G; CASSIBBA V; AMBROSETTI A; VENERI D; NADALI G; ZANOTTI R; TECCHIO C; PERONA G
      RELATIONSHIP BETWEEN DAUNORUBICIN DOSAGE DELIVERED DURING INDUCTION THERAPY AND OUTCOME IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    77. NADALI G; VINANTE F; AMBROSETTI A; TODESCHINI G; VENERI D; ZANOTTI R; MENEGHINI V; RICETTI MM; BENEDETTI F; VASSANELLI A; PERONA G; CHILOSI M; MENESTRINA F; FIACCHINI M; STEIN H; PIZZOLO G
      SERUM LEVELS OF SOLUBLE CD30 ARE ELEVATED IN THE MAJORITY OF UNTREATED PATIENTS WITH HODGKINS-DISEASE AND CORRELATE WITH CLINICAL-FEATURES AND PROGNOSIS

      Journal of clinical oncology
    78. VINANTE F; MOROSATO L; SIVIERO F; NADALI G; RIGO A; VENERI D; DESABATA D; VINCENZI C; CHILOSI M; SEMENZATO G; PIZZOLO G
      SOLUBLE FORMS OF P55-IL-2R-ALPHA, CD8, AND CD30 MOLECULES AS MARKERS OF LYMPHOID-CELL ACTIVATION IN INFECTIOUS-MONONUCLEOSIS

      Haematologica
    79. VINANTE F; MOROSATO L; SIVIERO F; NADALI G; RIGO A; VENERI D; DESABATA D; VINCENZI C; CHILOSI M; SEMENZATO G; PIZZOLO G
      SOLUBLE FORMS OF P55-IL-2R-ALPHA, CD8, AND CD30 MOLECULES AS MARKERS OF LYMPHOID-CELL ACTIVATION IN INFECTIOUS-MONONUCLEOSIS

      Haematologica
    80. NADALI G; VINANTE F; MOROSATO L; RICETTI MM; TECCHIO C; PIZZOLO G
      CLINICAL CORRELATIONS AND PROGNOSTIC-SIGNIFICANCE OF SERUM LEVELS OF SOLUBLE ICAM-1 IN HODGKINS-DISEASE

      Experimental hematology
    81. RIGO A; VINANTE F; RICETTI M; TECCHIO C; CASSATELLA MA; PIZZOLO G
      THE UP-REGULATION OF IL-8 MESSENGER-RNAS PARALLELS THE INDUCTION OF IL-1 MESSENGER-RNAS IN CULTURED MYELO-MONOCYTIC BLASTS

      Experimental hematology
    82. QIAO L; PIZZOLO G; MELAMED MR
      EFFECTS OF SELECTED CHEMOTHERAPEUTIC-AGENTS ON PCNA EXPRESSION IN PROSTATE CARCINOMA CELL-LINES

      Urological research
    83. PIZZOLO G; VINANTE F; MOROSATO L; NADALI G; CHILOSI M; GANDINI G; SINICCO A; RAITERI R; SEMENZATO G; STEIN H; PERONA G
      HIGH SERUM LEVEL OF THE SOLUBLE FORM OF CD30 MOLECULE IN THE EARLY PHASE OF HIV-1 INFECTION AS AN INDEPENDENT PREDICTOR OF PROGRESSION TO AIDS

      AIDS
    84. PIZZOLO G; VINANTE F; NADALI G; CHILOSI M; SEMENZATO G
      CIRCULATING SOLUBLE ICAM-1 IN PATIENTS WITH HODGKINS-DISEASE

      Immunology today
    85. MANETTI R; ANNUNZIATO F; BIAGIOTTI R; GIUDIZI MG; PICCINNI MP; GIANNARINI L; SAMPOGNARO S; PARRONCHI P; VINANTE F; PIZZOLO G; MAGGI E; ROMAGNANI S
      CD30 EXPRESSION BY CD8(-CELLS PRODUCING TYPE-2 HELPER CYTOKINES - EVIDENCE FOR LARGE NUMBERS OF CD8(+)CD30(+) T-CELL CLONES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION() T)

      The Journal of experimental medicine
    86. CHILOSI M; DOGLIONI C; MENESTRINA F; MONTAGNA L; RIGO A; LESTANI M; BARBARESCHI M; SCARPA A; MARIUZZI GM; PIZZOLO G
      ABNORMAL EXPRESSION OF THE P53-BINDING PROTEIN MDM2 IN HODGKINS-DISEASE

      Blood
    87. PIZZOLO G; VINANTE F; CHILOSI M; ROMAGNANI S; DELPRETE G
      CD30 ANTIGEN AND CELLULAR BIOLOGY OF REED-STERNBERG CELLS

      Blood
    88. TODESCHINI G; TECCHIO C; MENEGHINI V; PIZZOLO G; AMBROSETTI A; VENERI D; ZANOTTI R; PERONA G
      HIGH-DOSE DAUNORUBICIN (DNM) IN INDUCTION OF ADULT ALL PATIENTS - PRELIMINARY-RESULTS OF A PILOT PROTOCOL (ALLVR589)

      Blood
    89. AMBROSETTI A; PASINI F; DIMARCO A; SCOGNAMIGLIO F; TODESCHINI G; SABBIONI R; MENEGHINI V; PIZZOLO G
      PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMAS (PEL) OF HEAD AND NECK - REPORT OF 70 CASES

      Blood
    90. TODESCHINI G; TECCHIO C; DEGANI D; PIZZOLO G; NADALI G; MARRADI P; PASINI F; CETTO GL; VENERI D; PERONA G
      ANAPLASTIC LARGE-CELL LYMPHOMA CD30- CLINICAL-FEATURES AND LONG-TERM RESPONSE IN 40 CONSECUTIVE PATIENTS( (ALCL) )

      Blood
    91. TODESCHINI G; AMBROSETTI A; TECCHIO C; PIZZOLO G; MENEGHINI V; VENERI D; GIOVANNINI M; MENESTRINA F; PINTO F; FRANCHINI M; PERONA G
      3RD-GENERATION REGIMENS ARE THE THERAPY OF CHOICE IN PATIENTS WITH MEDIASTINAL LARGE B-CELL LYMPHOMA (MLBCL) WITH SCLEROSIS

      Blood
    92. CHILOSI M; MONTAGNA L; LESTANI M; PECORI S; MENGHI A; MENESTRINA F; VINANTE F; PIZZOLO G
      ABNORMAL EXPRESSION OF THE P53-BINDING PROTEIN MDM2 BY H-RS CELLS IN HODGKINS-DISEASE

      Blood
    93. PIZZOLO G; TECCHIO C; RIGO A; MOROSATO L; VINANTE F; ZANOTTI R; RICETTI MM; GALLATI H; CHILOSI M
      MEMBRANE AND SOLUBLE TNF RECEPTORS (P55 AND P75) IN ACUTE LEUKEMIAS

      Blood
    94. TODESCHINI G; TECCHIO C; DEGANI D; PIZZOLO G; MARRADI P; BALTER R; ZANOTTI R; RICETTI M; FRANCHINI M; PERONA G
      IMPROVED OUTCOME OF ADULT BURKITT-LYMPHOMA PATIENTS TREATED WITH AN INTENSIVE PEDIATRIC PROTOCOL (POG8617-8618)

      Blood
    95. TODESCHINI G; MURARI C; BONESI R; PIZZOLO G; AMADDI G; AMBROSETTI A; CERU S; PIACENTINI I; MARTINI N; MONTRESOR P; PERONA G
      ORAL ITRACONAZOLE PLUS NASAL AMPHOTERICIN-B FOR PROPHYLAXIS OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

      European journal of clinical microbiology & infectious diseases
    96. VINANTE F; RIGO A; VINCENZI C; RICETTI MM; MARROCCHELLA R; CHILOSI M; CASSATELLA MA; BONAZZI L; PIZZOLO G
      IL-8 MESSENGER-RNA EXPRESSION AND IL-8 PRODUCTION BY ACUTE MYELOID-LEUKEMIA CELLS

      Leukemia
    97. AMBROSETTI A; NADALI G; VINANTE F; CARLINI S; VENERI D; TODESCHINI G; MOROSATO L; DESABATA D; CHILOSI M; MAGGI E; PARRONCHI P; ROMAGNANI S; SEMENZATO G; PERONA G; PIZZOLO G
      SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HODGKIN DISEASE - RELATIONSHIP WITH CLINICAL STAGE, TUMOR BURDEN, AND TREATMENT OUTCOME

      Cancer
    98. PIZZOLO G; VINANTE F; NADALI G; RICETTI MM; MOROSATO L; MARROCCHELLA R; VINCENZI C; SEMENZATO G; CHILOSI M
      ICAM-1 TISSUE OVEREXPRESSION ASSOCIATED WITH INCREASED SERUM LEVELS OF ITS SOLUBLE FORM IN HODGKINS-DISEASE

      British Journal of Haematology
    99. CHILOSI M; LESTANI M; BENEDETTI A; MONTAGNA L; PEDRON S; SCARPA A; MENESTRINA F; HIROHASHI S; PIZZOLO G; SEMENZATO G
      CONSTITUTIVE EXPRESSION OF TENASCIN IN T-DEPENDENT ZONES OF HUMAN LYMPHOID-TISSUES

      The American journal of pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 20:09:33